Advertisement
Advertisement

ALDX

ALDX logo

Aldeyra Therapeutics, Inc.

1.73
USD
Sponsored
0.00
0.00%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

1.75

+0.02
+0.87%

Aldeyra Therapeutics, Inc. Profile

About

Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.

Info & Links

CEO

Todd C. Brady

Headquarters

131 HARTWELL AVENUE, SUITE 320
LEXINGTON, MA 02421, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.aldeyra.com

Auditor

BDO USA PC

Share holders

18

Employees

8

Aldeyra Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

105.26M

Enterprise Value

55.56M

Enterprise Value/EBITDA(ttm)

-1.92

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.16

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-63.75%

Return on Invested Capital(ttm)

-60.50%

Return on Assets(ttm)

-41.27%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-28.87M

Net Income Available to Common(ttm)

-27.37M

Diluted EPS(ttm)

-0.57

Share Statistics

Beta (5Y Monthly)

1.34

52-Week Change

-19.91%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

60.32M

Dividend Yield

0.00%

Float4

54.41M

% Held by Insiders

9.60%

% Held by Institutions

59.71%

Balance Sheet

Total Cash(mrq)

65.00M

Total Cash Per Share(mrq)

1.08

Total Debt(mrq)

15.30M

Total Debt/Equity(mrq)

34.46%

Current Ratio(mrq)

2.58%

Quick Ratio(mrq)

2.58%

Book Value Per Share(mrq)

0.74

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.56

Free Cash Flow(ytd)

-33.35M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement